ArticlePloS one2025
Sarcopenia modelling by portal vein ligation inducing hyperammonemia in rats.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia is a progressive muscle wasting condition often associated with hyperammonemia. However, no approved animal models of sarcopenia with hyperammonemia were reported. This study aimed to provide a surgical modelling of sarcopenia with hyperammonemia. Male Wistar rats were assigned by the method of random numbers (n = 6 per group) into experimental group with ligation of portal and pyloric veins or control group with sham surgery. Blood ammonia levels were measured directly after the surgery (20 min), after 1 h to observe acute damage in functioning shunts, and at the final endpoint (30 days). Rats were sacrificed with histological study of the liver, spleen, cerebral cortex, and skeletal muscles. Experimental rats revealed hyperammonemia at 30 days compared to controls, 70 µmol/L versus 38 µmol/L, p <0.05. No significant changes were observed in liver morphology between the groups, approving hyperammonemia without liver damage. Splenomegaly and Gamna-Gandy bodies in the spleen of experimental rats indirectly evidenced functionable portosystemic shunting after the ligation. Cerebral cortex showed a significant decrease in neurons of experimental animals, 7.6 ± 2.5 NeuN+cells vs 13 ± 2 in controls, p <0.05. Skeletal muscles revealed a significant difference of muscle fiber diameter between the groups, 20.2 ± 2.1 µm in the experimental group vs 30.7 ± 4.3 µm in controls, at p < 0.001. A model of sarcopenia with hyperammonemia was established with concomitant changes in cerebral histology revealed. This model may be a valuable tool for studies of sarcopenia and related therapeutic options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.